Lidocaine (IV — Regional Anaesthesia)
Brand names: Xylocaine
This page concerns intravenous lidocaine used for regional anaesthesia (notably intravenous regional anaesthesia / Bier's block) and as a perioperative analgesic adjunct in orthopaedic and trauma care.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Lidocaine is an amide local anaesthetic that blocks voltage-gated sodium channels, preventing nerve impulse conduction; systemically it also has analgesic and anti-hyperalgesic effects.
Prescribing in practice
- The principal hazard is local anaesthetic systemic toxicity (LAST) — perioral numbness and tinnitus progressing to seizures, cardiac arrhythmia and arrest — so respect maximum doses, use a functioning tourniquet for Bier's block and have lipid emulsion and resuscitation immediately available.
- For intravenous regional anaesthesia the tourniquet must not be released prematurely, as sudden systemic release of the agent can precipitate toxicity.
- Use with caution and reduced dosing in hepatic impairment, low cardiac output, the elderly and those with conduction defects; avoid in severe heart block.
Monitoring
Monitor ECG, blood pressure, conscious level and for early signs of systemic toxicity throughout administration.
Counselling the patient
- Report ringing in the ears, tingling around the mouth, a metallic taste or dizziness immediately.
- The tourniquet (cuff) stays inflated for a set time for your safety.
- This provides numbness and pain relief for your procedure.
Evidence & guidelines
AAGBI/Association of Anaesthetists guidance on managing severe local anaesthetic systemic toxicity underpins safe intravenous lidocaine use and immediate lipid-emulsion availability.
Reference: AAGBI LAST Guidelines 2010; ASRA Regional Anaesthesia Guidelines; Miller's Anaesthesia; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Modified Mallampati Classification · Airway Assessment
- ASA Physical Status Classification · Pre-operative Risk
- Aldrete Score for Post-Anaesthesia Discharge · Post-operative
- Local Anaesthetic Maximum Dose Calculator · Drug Dosing
- Mallampati Score (Airway Assessment) · Airway Assessment
- ASA Physical Status Classification · Perioperative Risk
- Hip Fracture Management · NICE CG124 / BOA 2020
- Distal Radius Fracture · BOA / NICE
- Ankle Fracture Management · BOA / Lauge-Hansen classification
- Metastatic Spinal Cord Compression · NICE CG75 2020
- Open Fracture Management · BOA/BAPRAS 2017
- OrthoPath: Upper Limb ED Triage · OrthoPath ED Tool — ReviseMRCEM.com